Novo Nordisk launched Wegovy in China, targeting obesity with a 1,400 yuan price, competing with Eli Lilly’s upcoming drug.
Wegovy Launch in China
Novo Nordisk has launched its weight-loss drug, Wegovy, in China after receiving local health approval. This move intensifies competition with Eli Lilly, which also has a weight-loss treatment pending release in the country.
Cost and Accessibility
Wegovy costs 1,400 yuan (approximately $194) for four injections, significantly cheaper than in the U.S. However, it isn’t covered by national healthcare, requiring patients to pay out of pocket.
Source link : Wegovy: The Popular Weight-Loss Drug Now Available in China by China News
